Additional Details

  • Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)

    Beaumont Hospital, Royal Oak
    Royal Oak MI. 48073
    View Details

  • Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)

    Indiana University Health
    Indianapolis IN. 46202
    View Details

  • Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)

    Baylor University Medical Center
    Dallas TX. 75246
    View Details

  • Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)

    Icahn School of Medicine at Mount Sinai
    New York NY. 10029
    View Details

  • 129Xe MRI Cardiopulmonary

    Duke University Medical Center
    Durham NC. 27710
    View Details

  • Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

    University of Cincinnati Medical Center
    Cincinnati OH. 45219
    View Details

  • Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

    Peter Morton Medical Building
    Los Angeles CA. 90095
    View Details

  • Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

    Saint Luke's Hospital of Kansas City
    Kansas City MO. 64111
    View Details

  • Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

    St.Joseph's Healthcare Hamilton
    Hamilton ON. L8N 4A6
    View Details

  • Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

    Mercy Health St.Vincent Medical Center LLC
    Toledo OH. 43608
    View Details

  • Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

    Intermountain Medical Center
    Murray UT. 84107
    View Details

  • Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

    UC Davis Health Medical Center
    Sacramento CA. 95817
    View Details

  • Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

    Duke University Medical Center
    Durham NC. 27710
    View Details

  • Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

    University Hospital and UW Health Clinics
    Madison WI. 53792
    View Details

  • Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

    Mayo Clinic
    Jacksonville FL. 32224
    View Details

  • Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

    University of California Irvine Medical Center
    Orange CA. 92868
    View Details

  • Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

    University of Louisville Healthcare Outpatient Research Clinic
    Louisville KY. 40202
    View Details

  • Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

    University of Kentucky
    Lexington KY. 45227
    View Details

  • Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

    Massachusetts General Hospital
    Boston MA. 02114
    View Details

  • Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

    Loyola University Medical Center
    Maywood IL. 60153
    View Details